These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7788913)

  • 21. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
    Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
    Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curve.
    Lehmann KG; Melkert R; Serruys PW
    Circulation; 1996 Mar; 93(6):1123-32. PubMed ID: 8653832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of haematological parameters before coronary angioplasty on subsequent restenosis.
    Avci A; Boyaci A; Cağli K; Cosgun A; Gokce V; Duru E; Korkmaz S
    Acta Cardiol; 2004 Jun; 59(3):263-8. PubMed ID: 15255457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
    Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
    Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
    Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of preprocedural fibrinogen concerning coronary stenting.
    Otsuka M; Hayashi Y; Ueda H; Imazu M; Kohno N
    Atherosclerosis; 2002 Oct; 164(2):371-8. PubMed ID: 12204810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
    de Groote P; Bauters C; McFadden EP; Lablanche JM; Leroy F; Bertrand ME
    Circulation; 1995 Feb; 91(4):968-72. PubMed ID: 7850983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction.
    Bauters C; Lablanche JM; Van Belle E; Niculescu R; Meurice T; Mc Fadden EP; Bertrand ME
    Circulation; 1997 Nov; 96(9):2854-8. PubMed ID: 9386149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis.
    Huber K; Jörg M; Probst P; Schuster E; Lang I; Kaindl F; Binder BR
    Thromb Haemost; 1992 Feb; 67(2):209-13. PubMed ID: 1621240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
    Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
    Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
    J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
    Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
    Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restenosis or rapid progression in non-dilated sites are not predictors of late spontaneous coronary events.
    Benchimol D; Dubroca B; Dufourq P; Benchimol H; Couffinhal T; Dartigues JF; Bonnet J
    Int J Cardiol; 1997 Jul; 60(2):201-11. PubMed ID: 9226292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.